In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

A new study from Karolinska Institutet suggests that some widely used heartburn medications may be linked to kidney problems ...

Using two types of cardiovascular drugs together could help to treat fatty liver disease and reduce the number of severe cases. This is the finding of researchers from the University of Barcelona (UB) ...

Two everyday medications, pemafibrate and telmisartan, could offer a safer, faster route to treating fatty liver disease. Scientists in Barcelona found the drug duo reduced liver fat and ...

Semaglutide reduces cardiovascular events by 23% and direct heart disease death risk by 26% compared to dulaglutide in older ...

Building on earlier studies showing its benefits for type 2 diabetes, a new study has revealed the experimental drug IC7Fc ...

Researchers say GLP-1 drugs prescribed for weight loss like Ozempic and Mounjaro are more effective at reducing heart health risks in people with type 2 diabetes than other types of glucose-lowering ...

A new experimental therapy helps restore the heart’s flexibility in models of stiffened heart failure. Michael Gotthardt and his colleagues at the Max Delbrück Center are working with U.S. researchers ...

People who rely on antihistamines to manage allergies may need to exercise caution around sweets with food colouring like ...